PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2850161-4	1988	In the presence of cytochalasin B, the inhibitory effect of eglin-c on O-2 release following stimulation with FMLP became more pronounced.	Cytochalasin B	19-33	immunoglobulin kappa variable 1D-39	Homo sapiens	71-74	
6329209-3	1984	O-2 generation is markedly reduced if cells are not preincubated with cytochalasin B prior to contact with ZAS .	Cytochalasin B	70-84	immunoglobulin kappa variable 1D-39	Homo sapiens	0-3	
2984301-3	1985	Nicotine, however, inhibited both extracellular release of lysosomal enzymes from PMN and O-2 production of PMN, both of which were induced by fMet-Leu-Phe and cytochalasin B.	Cytochalasin B	160-174	immunoglobulin kappa variable 1D-39	Homo sapiens	90-93	
7093528-4	1982	Morphological observations suggested that the enhancement of O2- and H2O2 release was caused by excessive release of the oxygen metabolites into the extracellular medium from incompletely formed phagocytic vacuoles as was observed with cytochalasin-B-treated cells.	Cytochalasin B	236-250	immunoglobulin kappa variable 1D-39	Homo sapiens	61-73	
6324816-4	1984	A time-dependent desensitization for O-2 production was demonstrated in neutrophilis which were stimulated with AGEPC prior to contact with cytochalasin B.	Cytochalasin B	140-154	immunoglobulin kappa variable 1D-39	Homo sapiens	37-40	
6308042-7	1983	Prolonged O-2 release also follows fMLP stimulation in suspensions of PMN pretreated with cytochalasin B, in which case aggregation becomes irreversible during the 20-min burst.	Cytochalasin B	90-104	immunoglobulin kappa variable 1D-39	Homo sapiens	10-13	
219119-7	1979	Pretreatment of the PMNs with cytochalasin B enhanced the release of O-2 by PMNs exposed to FMLP.	Cytochalasin B	30-44	immunoglobulin kappa variable 1D-39	Homo sapiens	69-72